Irvine-based ChromaDex, a publicly held developer of phytochemical ingredients, said it received a strategic investment from DSM Venturing, the venture capital arm of Royal DSM. Size of the investment was not announced. Royal DSM is a major life sciences and material sciences company with operations in the food, dietary supplement, pharmaceuticals, and many other industries. ChromaDex provides ingredients for the dietary supplement, food, beverage, cosmetic, and pharmaceuticals market.
Top NewsMonday, October 21, 2013
ChromaDex Gets Strategic Investment